Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

SCH-58500 in Treating Patients With Primary Ovarian, Fallopian Tube, or Peritoneal Cancer (C95084)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Merck Sharp & Dohme Corp.
ClinicalTrials.gov Identifier:
NCT00002960
First received: November 1, 1999
Last updated: February 3, 2016
Last verified: February 2016